Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Cancer and Metastasis Reviews
Published in: Cancer and Metastasis Reviews 4/2018

01-12-2018

Mitochondrial polymorphisms contribute to aging phenotypes in MNX mouse models

Authors: Carolyn J. Vivian, Travis M. Hagedorn, Roy A. Jensen, Amanda E. Brinker, Danny R. Welch

Published in: Cancer and Metastasis Reviews | Issue 4/2018

Login to get access

Abstract

Many inbred strains of mice develop spontaneous tumors as they age. Recent awareness of the impacts of mitochondrial DNA (mtDNA) on cancer and aging has inspired developing a mitochondrial-nuclear exchange (MNX) mouse model in which nuclear DNA is paired with mitochondrial genomes from other strains of mouse. MNX mice exhibit mtDNA influences on tumorigenicity and metastasis upon mating with transgenic mice. However, we also wanted to investigate spontaneous tumor phenotypes as MNX mice age. Utilizing FVB/NJ, C57BL/6J, C3H/HeN, and BALB/cJ wild-type inbred strains, previously documented phenotypes were observed as expected in MNX mice with the same nuclear background. However, aging nuclear matched MNX mice exhibited decreased occurrence of mammary tumors in C3H/HeN mice containing C57BL/6J mitochondria compared to wild-type C3H/HeN mice. Although aging tumor phenotypes appear to be driven by nuclear genes, evidence suggesting that some differences are modified by the mitochondrial genome is presented.
Appendix
Available only for authorised users
Literature
1.
Dragani, T. A. (2003). 10 years of mouse cancer modifier loci: human relevance. Cancer Research, 63(12), 3011–3018.PubMed
2.
Altman, P. L., & Katz, D. D. (1979). Inbred and genetically defined strains of laboratory animals. Part 2. Hamster, guinea pig, rabbit and chicken (Vol. 1). Bethesda: Federation of American Societies for Experimental Biology.
3.
Altman, P. L., & Katz, D. D. (1979). Inbred and genetically defined strains of laboratory animals. Part 1. Mouse and rat (Vol. 1). Bethesda: Federation of American Societies for Experimental Biology.
4.
Stern, M. C., & Conti, C. J. (1996). Genetic susceptibility to tumor progression in mouse skin carcinogenesis. Progress in Clinical and Biological Research, 395, 47–55.PubMed
5.
6.
Heston, W. E., & Vlahakis, G. (1971). Mammary tumors, plaques, and hyperplastic alveolar nodules in various combinations of mouse inbred strains and the different lines of the mammary tumor virus. International Journal of Cancer, 7(1), 141–148.CrossRefPubMed
7.
Guy, C. T., Cardiff, R. D., & Muller, W. J. (1992). Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Molecular and Cellular Biology, 12(3), 954–961.CrossRefPubMedPubMedCentral
8.
Cardiff, R. D., & Muller, W. J. (1993). Transgenic mouse models of mammary tumorigenesis. Cancer Surveys, 16, 97–113.PubMed
9.
Muller, W. J., Ho, J., & Siegel, P. M. (1998). Oncogenic activation of Neu/ErbB-2 in a transgenic mouse model for breast cancer. Biochemical Society Symposia, 63, 149–157.
10.
Walrath, J. C., Hawes, J. J., Van Dyke, T., & Reilly, K. M. (2010). Genetically engineered mouse models in cancer research. Advances in Cancer Research, 106, 113–164.CrossRefPubMedPubMedCentral
11.
Walton, J. B., Farquharson, M., Mason, S., Port, J., Kruspig, B., Dowson, S., Stevenson, D., Murphy, D., Matzuk, M., Kim, J., Coffelt, S., Blyth, K., & McNeish, I. A. (2017). CRISPR/Cas9-derived models of ovarian high grade serous carcinoma targeting Brca1, Pten and Nf1, and correlation with platinum sensitivity. Scientific Reports, 7(1), 16827.CrossRefPubMedPubMedCentral
12.
13.
Taketo, M., Schroeder, A. C., Mobraaten, L. E., Gunning, K. B., Hanten, G., Fox, R. R., Roderick, T. H., Stewart, C. L., Lilly, F., & Hansen, C. T. (1991). FVB/N: an inbred mouse strain preferable for transgenic analyses. Proceedings of the National Academy of Sciences of the United States of America, 88(6), 2065–2069.CrossRefPubMedPubMedCentral
14.
Mahler, J. F., Stokes, W., Mann, P. C., Takaoka, M., & Maronpot, R. R. (1996). Spontaneous lesions in aging FVB/N mice. Toxicologic Pathology, 24(6), 710–716.CrossRefPubMed
15.
Fetterman, J. L., Zelickson, B. R., Johnson, L. W., Moellering, D. R., Westbrook, D. G., Pompilius, M., Sammy, M. J., Johnson, M., Dunham-Snary, K. J., Cao, X., Bradley, W. E., Zhang, J., Wei, C. C., Chacko, B., Schurr, T. G., Kesterson, R. A., Dell’italia, L. J., Darley-Usmar, V. M., Welch, D. R., & Ballinger, S. W. (2013). Mitochondrial genetic background modulates bioenergetics and susceptibility to acute cardiac volume overload. Biochemical Journal, 455(2), 157–167.CrossRefPubMed
16.
Zheng, Q. Y., Johnson, K. R., & Erway, L. C. (1999). Assessment of hearing in 80 inbred strains of mice by ABR threshold analyses. Hearing Research, 130(1–2), 94–107.CrossRefPubMedPubMedCentral
17.
Bult, C. J., Krupke, D. M., Begley, D. A., Richardson, J. E., Neuhauser, S. B., Sundberg, J. P., & Eppig, J. T. (2015). Mouse tumor biology (MTB): a database of mouse models for human cancer. Nucleic Acids Research, 43(Database issue), D818–D824.CrossRefPubMed
18.
Smith, C. L., Blake, J. A., Kadin, J. A., Richardson, J. E., Bult, C. J., & Mouse Genome Database, G. (2018). Mouse genome database (MGD)-2018: knowledgebase for the laboratory mouse. Nucleic Acids Research, 46(D1), D836–D842.CrossRefPubMed
19.
Bagg, H. J. (1936). Functional activity of the mammary gland in relation to extra-chromosomal influence in the incidence of mammary tumors. Science, 83(2155), 374–375.CrossRefPubMed
20.
Adair, F. E., & Bagg, H. J. (1931). Experimental and clinical studies on the treatment of cancer by dichlorethylsulphide mustard gas. Annals of Surgery, 93(1), 190–199.CrossRefPubMedPubMedCentral
21.
Ebbesen, P. (1971). Reticulosarcoma and amyloid development in BALB/c mice inoculated with syngeneic cells from young and old donors. Journal of the National Cancer Institute, 47(6), 1241–1245.PubMed
22.
Myers, D. D., Meier, H., & Huebner, R. J. (1970). Prevalence of murine C-type RNA virus group specific antigen in inbred strains of mice. Life Sciences. Part 2: Biochemistry, General and Molecular Biology, 9(18), 1071–1080.CrossRef
23.
Hoag, W. G. (1963). Spontaneous cancer in mice. Annals of the New York Academy of Sciences, 108, 805–831.CrossRefPubMed
24.
Cunliffe-Beamer, T. L., & Feldman, D. B. (1976). Vaginal septa in mice: incidence, inheritance, and effect on reproductive, performance. Laboratory Animal Science, 26(6 Pt 1), 895–898.PubMed
25.
26.
Braunschweiger, P. G., Poulakos, L., & Schiffer, L. M. (1977). Cell kinetics in vivo and in vitro for C3H/He spontaneous mammary tumors. Journal of the National Cancer Institute, 59(4), 1197–1204.CrossRefPubMed
27.
Lacour, F., Delage, G., & Chianale, C. (1975). Reduced incidence of spontaneous mammary tumors in C3H/He mice after treatment with polyadenylate-polyuridylate. Science, 187(4173), 256–257.CrossRefPubMed
28.
Manenti, G., Binelli, G., Gariboldi, M., Canzian, F., De Gregorio, L., Falvella, F. S., et al. (1994). Multiple loci affect genetic predisposition to hepatocarcinogenesis in mice. Genomics, 23(1), 118–124.CrossRefPubMed
29.
Sidman, R. L., & Green, M. C. (1965). Retinal degeneration in the mouse: location of the Rd locus in linkage group Xvii. Journal of Heredity, 56, 23–29.CrossRefPubMed
30.
Abiola, O., Angel, J. M., Avner, P., Bachmanov, A. A., Belknap, J. K., Bennett, B., Blankenhorn, E. P., Blizard, D. A., Bolivar, V., Brockmann, G. A., Buck, K. J., Bureau, J. F., Casley, W. L., Chesler, E. J., Cheverud, J. M., Churchill, G. A., Cook, M., Crabbe, J. C., Crusio, W. E., Darvasi, A., de Haan, G., Dermant, P., Doerge, R. W., Elliot, R. W., Farber, C. R., Flaherty, L., Flint, J., Gershenfeld, H., Gibson, J. P., Gu, J., Gu, W., Himmelbauer, H., Hitzemann, R., Hsu, H. C., Hunter, K., Iraqi, F. F., Jansen, R. C., Johnson, T. E., Jones, B. C., Kempermann, G., Lammert, F., Lu, L., Manly, K. F., Matthews, D. B., Medrano, J. F., Mehrabian, M., Mittlemann, G., Mock, B. A., Mogil, J. S., Montagutelli, X., Morahan, G., Mountz, J. D., Nagase, H., Nowakowski, R. S., O'Hara, B. F., Osadchuk, A. V., Paigen, B., Palmer, A. A., Peirce, J. L., Pomp, D., Rosemann, M., Rosen, G. D., Schalkwyk, L. C., Seltzer, Z., Settle, S., Shimomura, K., Shou, S., Sikela, J. M., Siracusa, L. D., Spearow, J. L., Teuscher, C., Threadgill, D. W., Toth, L. A., Toye, A. A., Vadasz, C., van Zant, G., Wakeland, E., Williams, R. W., Zhang, H. G., Zou, F., & Complex Trait Consortium. (2003). The nature and identification of quantitative trait loci: a community’s view. Nature Reviews Genetics, 4(11), 911–916.CrossRefPubMed
31.
Little, C. C., & Tyzzer, E. E. (1916). Further experimental studies on the inheritance of susceptibility to a transplantable tumor, carcinoma (J. W. A.) of the Japanese waltzing mouse. Journal of Medical Research, 33(3), 393–453.PubMed
32.
Albert, F. W., & Kruglyak, L. (2015). The role of regulatory variation in complex traits and disease. Nature Reviews Genetics, 16(4), 197–212.CrossRefPubMed
33.
Mackay, T. F. C. (2014). Epistasis and quantitative traits: using model organisms to study gene-gene interactions. Nature Reviews Genetics, 15(1), 22–33.CrossRefPubMed
34.
35.
Plomin, R., Haworth, C. M., & Davis, O. S. (2009). Common disorders are quantitative traits. Nature Reviews Genetics, 10(12), 872–878.CrossRefPubMed
36.
37.
Brinker, A. E., Vivian, C. J., Koestler, D. C., Tsue, T. T., Jensen, R. A., & Welch, D. R. (2017). Mitochondrial haplotype alters mammary cancer tumorigenicity and metastasis in an oncogenic driver-dependent manner. Cancer Research, 77(24), 6941–6949.CrossRefPubMedPubMedCentral
38.
Vivian, C. J., Brinker, A. E., Graw, S., Koestler, D. C., Legendre, C., Gooden, G. C., Salhia, B., & Welch, D. R. (2017). Mitochondrial genomic backgrounds affect nuclear DNA methylation and gene expression. Cancer Research, 77(22), 6202–6214.CrossRefPubMedPubMedCentral
39.
Feeley, K. P., Bray, A. W., Westbrook, D. G., Johnson, L. W., Kesterson, R. A., Ballinger, S. W., & Welch, D. R. (2015). Mitochondrial genetics regulate breast cancer tumorigenicity and metastatic potential. Cancer Research, 75(20), 4429–4436.CrossRefPubMedPubMedCentral
40.
Gorman, G. S., Chinnery, P. F., DiMauro, S., Hirano, M., Koga, Y., McFarland, R., Suomalainen, A., Thorburn, D. R., Zeviani, M., & Turnbull, D. M. (2016). Mitochondrial diseases. Nature Reviews Disease Primers, 2, 16080.CrossRefPubMed
41.
Wallace, D. C., & Chalkia, D. (2013). Mitochondrial DNA genetics and the heteroplasmy conundrum in evolution and disease. Cold Spring Harbor Perspectives in Biology, 5(11), a021220.CrossRefPubMedPubMedCentral
42.
Wallace, D. C. (2005). A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annual Review of Genetics, 39, 359–407.CrossRefPubMedPubMedCentral
43.
Wallace, D. C., & Fan, W. (2010). Energetics, epigenetics, mitochondrial genetics. Mitochondrion, 10(1), 12–31.CrossRefPubMed
44.
Picard, M., Zhang, J., Hancock, S., Derbeneva, O., Golhar, R., Golik, P., O'Hearn, S., Levy, S., Potluri, P., Lvova, M., Davila, A., Lin, C. S., Perin, J. C., Rappaport, E. F., Hakonarson, H., Trounce, I. A., Procaccio, V., & Wallace, D. C. (2014). Progressive increase in mtDNA 3243A>G heteroplasmy causes abrupt transcriptional reprogramming. Proceedings of the National Academy of Sciences of the United States of America, 111(38), E4033–E4042.CrossRefPubMedPubMedCentral
45.
Wallace, D. C. (2016). Genetics: Mitochondrial DNA in evolution and disease. Nature, 535(7613), 498–500.CrossRefPubMed
46.
Mishmar, D., Ruiz-Pesini, E., Golik, P., Macaulay, V., Clark, A. G., Hosseini, S., Brandon, M., Easley, K., Chen, E., Brown, M. D., Sukernik, R. I., Olckers, A., & Wallace, D. C. (2003). Natural selection shaped regional mtDNA variation in humans. Proceedings of the National Academy of Sciences of the United States of America, 100(1), 171–176.CrossRefPubMed
47.
Takibuchi, G., Imanishi, H., Morimoto, M., Ishikawa, K., Nakada, K., Toyama-Sorimachi, N., Kikkawa, Y., Takenaga, K., & Hayashi, J. I. (2013). Polymorphic mutations in mouse mitochondrial DNA regulate a tumor phenotype. Mitochondrion, 13(6), 881–887.CrossRefPubMed
48.
Goios, A., Gusmao, L., Rocha, A. M., Fonseca, A., Pereira, L., Bogue, M., et al. (2008). Identification of mouse inbred strains through mitochondrial DNA single-nucleotide extension. Electrophoresis, 29(23), 4795–4802.CrossRefPubMed
49.
Sflomos, G., Dormoy, V., Metsalu, T., Jeitziner, R., Battista, L., Scabia, V., Raffoul, W., Delaloye, J. F., Treboux, A., Fiche, M., Vilo, J., Ayyanan, A., & Brisken, C. (2016). A preclinical model for ERalpha-positive breast cancer points to the epithelial microenvironment as determinant of luminal phenotype and hormone response. Cancer Cell, 29(3), 407–422.CrossRefPubMed
50.
Goios, A., Pereira, L., Bogue, M., Macaulay, V., & Amorim, A. (2007). mtDNA phylogeny and evolution of laboratory mouse strains. Genome Research, 17(3), 293–298.CrossRefPubMedPubMedCentral
51.
52.
Roubertoux, P. L., Sluyter, F., Carlier, M., Marcet, B., Maarouf-Veray, F., Cherif, C., et al. (2003). Mitochondrial DNA modifies cognition in interaction with the nuclear genome and age in mice. Nature Genetics, 35(1), 65–69.CrossRefPubMed
53.
Bussard, K. M., & Siracusa, L. D. (2017). Understanding mitochondrial polymorphisms in cancer. Cancer Research, 77(22), 6051–6059.CrossRefPubMed
54.
Trifunovic, A., Wredenberg, A., Falkenberg, M., Spelbrink, J. N., Rovio, A. T., Bruder, C. E., Bohlooly-Y, M., Gidlöf, S., Oldfors, A., Wibom, R., Törnell, J., Jacobs, H. T., & Larsson, N. G. (2004). Premature ageing in mice expressing defective mitochondrial DNA polymerase. Nature, 429(6990), 417–423.CrossRefPubMed
55.
Chatterjee, A., Mambo, E., & Sidransky, D. (2006). Mitochondrial DNA mutations in human cancer. Oncogene, 25(34), 4663–4674.CrossRefPubMed
56.
Park, C. B., & Larsson, N. G. (2011). Mitochondrial DNA mutations in disease and aging. Journal of Cell Biology, 193(5), 809–818.CrossRefPubMed
57.
Asano, T., Yao, Y., Zhu, J., Li, D., Abbruzzese, J. L., & Reddy, S. A. (2004). The PI 3-kinase/Akt signaling pathway is activated due to aberrant Pten expression and targets transcription factors NF-kappaB and c-Myc in pancreatic cancer cells. Oncogene, 23(53), 8571–8580.CrossRefPubMed
58.
Stewart, J. B., Freyer, C., Elson, J. L., & Larsson, N. G. (2008). Purifying selection of mtDNA and its implications for understanding evolution and mitochondrial disease. Nature Reviews Genetics, 9(9), 657–662.CrossRefPubMed
59.
60.
McCredie, J. A., Inch, W. R., & Sutherland, R. M. (1971). Differences in growth and morphology between the spontaneous C3H mammary carcinoma in the mouse and its syngeneic transplants. Cancer, 27(3), 635–642.CrossRefPubMed
61.
Pontual, E. V., Carvalho, B. E., Bezerra, R. S., Coelho, L. C., Napoleao, T. H., & Paiva, P. M. (2012). Caseinolytic and milk-clotting activities from Moringa oleifera flowers. Food Chemistry, 135(3), 1848–1854.CrossRefPubMed
Metadata
Title
Mitochondrial polymorphisms contribute to aging phenotypes in MNX mouse models
Authors
Carolyn J. Vivian
Travis M. Hagedorn
Roy A. Jensen
Amanda E. Brinker
Danny R. Welch
Publication date
01-12-2018
Publisher
Springer US
Published in
Cancer and Metastasis Reviews / Issue 4/2018
Print ISSN: 0167-7659
Electronic ISSN: 1573-7233
DOI
https://doi.org/10.1007/s10555-018-9773-6

Other articles of this Issue 4/2018

Cancer and Metastasis Reviews 4/2018 Go to the issue

NON-THEMATIC REVIEW

WNT5A as a therapeutic target in breast cancer

OriginalPaper

Cancer-associated fibroblasts as key regulators of the breast cancer tumor microenvironment

NON-THEMATIC REVIEW

Perspectives on the role of brain cellular players in cancer-associated brain metastasis: translational approach to understand molecular mechanism of tumor progression

NON-THEMATIC REVIEW

Developing TRAIL/TRAIL death receptor-based cancer therapies

Announcement

Biography—Stephanie Tucker

NON-THEMATIC REVIEW

Pro-survival autophagy and cancer cell resistance to therapy
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits